KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Cash from Financing Activities (2016 - 2025)

Gilead Sciences' Cash from Financing Activities history spans 17 years, with the latest figure at -$1.3 billion for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 155.88% year-over-year to -$1.3 billion; the TTM value through Dec 2025 reached -$7.7 billion, down 125.6%, while the annual FY2025 figure was -$7.7 billion, 125.6% down from the prior year.
  • Cash from Financing Activities reached -$1.3 billion in Q4 2025 per GILD's latest filing, up from -$1.5 billion in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $2.3 billion in Q4 2024 to a low of -$3.5 billion in Q3 2021.
  • Average Cash from Financing Activities over 5 years is -$1.6 billion, with a median of -$1.5 billion recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: crashed 1582.44% in 2021, then skyrocketed 305.64% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$1.9 billion in 2021, then grew by 19.98% to -$1.6 billion in 2022, then rose by 29.28% to -$1.1 billion in 2023, then surged by 305.64% to $2.3 billion in 2024, then crashed by 155.88% to -$1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Cash from Financing Activities are -$1.3 billion (Q4 2025), -$1.5 billion (Q3 2025), and -$1.6 billion (Q2 2025).